The HBP1 transcriptional repressor and the p38 MAP kinase: Unlikely partners in G1 regulation and tumor suppression

Gene

Volumn 336, Issue 1, 2004, Pages 1-13

  Yee, Amy S ^a,b   Paulson, Eric K ^a,b   McDevitt, Michael A ^c   Rieger Christ, Kimberly ^d   Summerhayes, Ian ^d   Berasi, Stephen P ^a   Kim, Jiyoung ^a,e   Huang, Chun Yin ^b   Zhang, Xiaowei ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

acute myelogenous leukemia; adenematous polypoisis coli; AML; APC; ataxin; Ataxin homology domain; AXH; Chromosome 7; glycogen synthase beta; GSK3 ; HBP1; HDAC; HMG box protein 1; p38 MAPK; p47 phox; ROS; Tumor suppressor; Wnt signaling

Indexed keywords

CYCLIN D1; GROWTH FACTOR; HISTONE H1; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; PROTEIN P47; REACTIVE SULFUR SPECIES; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HMG BOX PROTEIN 1; UNCLASSIFIED DRUG; WNT PROTEIN;

CANCER INHIBITION; CELL CYCLE G1 PHASE; DNA BINDING; GENE CONTROL; GENE LOCUS; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HIGH MOBILITY GROUP BOX DOMAIN; HUMAN; ONCOGENE C MYB; ONCOGENE C MYC; POSITION EFFECT VARIEGATION; PRIORITY JOURNAL; REVIEW; SENESCENCE;

AMINO ACID SEQUENCE; ANIMALS; G1 PHASE; HIGH MOBILITY GROUP PROTEINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 3242772188     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2004.04.004     Document Type: Review

References (90)

1. Arnold R.S., Shi J., Murad E., Whalen A.M., Sun C.Q., Polavarapu R., Parthasarathy S., Petros J.A., Lambeth J.D. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5550-5555
2. Berasi S.P., Xiu M., Yee A.S., Paulson K.E. HBP1 repression of the p47 phox gene: cell cycle regulation via the NADPH oxidase. Mol. Cell. Biol. 24:2004;3011-3024
3. Bewley C.A., Gronenborn A.M., Clore G.M. Minor groove-binding architectural proteins: structure, function, and DNA recognition. Annu. Rev. Biophys. Biomol. Struct. 27:1998;105-131
4. Bienz M., Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 103:2000;311-320
5. Brancho D., Tanaka N., Jaeschke A., Ventura J.J., Kelkar N., Tanaka Y., Kyuuma M., Takeshita T., Flavell R.A., Davis R.J. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17:2003;1969-1978
6. Bulavin D.V., Demidov O.N., Saito S., Kauraniemi P., Phillips C., Amundson S.A., Ambrosino C., Sauter G., Nebreda A.R., Anderson C.W., Kallioniemi A., Fornace A.J. Jr., Appella E. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31:2002;210-215
7. Campisi J. Cancer and ageing: rival demons? Nat. Rev. Cancer. 3:2003;339-349
8. Cheng G., Cao Z., Xu X., van Meir E.G., Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene. 269:2001;131-140
9. Classon M., Dyson N. p107 and p130: versatile proteins with interesting pockets. Exp. Cell Res. 264:2001;135-147
10. Classon M., Kennedy B.K., Mulloy R., Harlow E. Opposing roles of pRB and p107 in adipocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10826-10831
11. Classon M., Salama S., Gorka C., Mulloy R., Braun P., Harlow E. Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10820-10825
12. Damalas A., Ben-Ze'ev A., Simcha I., Shtutman M., Leal J.F., Zhurinsky J., Geiger B., Oren M. Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO. J. 18:1999;3054-3063
13. de Chiara C., Giannini C., Adinolfi S., de Boer J., Guida S., Ramos A., Jodice C., Kioussis D., Pastore A. The AXH module: an independently folded domain common to ataxin-1 and HBP1. FEBS Lett. 551:2003;107-112
14. Driouch K., Briffod M., Bieche I., Champeme M.H., Lidereau R. Location of several putative genes possibly involved in human breast cancer progression. Cancer Res. 58:1998;2081-2086
15. Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., She W.C., Luchak J.M., Martinez P., Turiegano E., Benito J., Capovilla M., Skinner P.J., McCall A., Canal I., Orr H.T., Zoghbi H.Y., Botas J. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature (Lond.). 408:2000;101-106. (in process citation)
16. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15:2003;247-254
17. Galceran J., Farinas I., Depew M.J., Clever H., Grosschedl R. Wnt 3a-/- like phenotype and limb deficiency in Lef1-/-TCF-/-mice. Genes and Dev. 13:1999;709-717
18. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
19. Haq R., Brenton J.D., Takahashi M., Finan D., Finkielsztein A., Damaraju S., Rottapel R., Zanke B. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res. 62:2002;5076-5082
20. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., daCosta L., Morin P.J., Vogelstein B., Kinzler K. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512
21. Heintz N. Biomedicine. Ataxin-1 regulators in the spotlight. Science. 301:2003;59-60
22. Huang E., Ishida S., Pittman J., Dressman H., Bild A., Kloos M., D'Amico M., Pestell R.G., West M., Nevins J.R. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat. Genet. 34:2003;226-230
23. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 275:1997;1649-1652
24. Iwasa H., Han J., Ishikawa F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells. 8:2003;131-144
25. Joneson T., Bar-Sagi D. A Rac1 effector site controlling mitogenesis through superoxide production. J. Biol. Chem. 273:1998;17991-17994
26. Kim G.Y., Mercer S.E., Ewton D.Z., Yan Z., Jin K., Friedman E. The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylation. J. Biol. Chem. 277:2002;29792-29802
27. Koike M., Tasaka T., Spira S., Tsuruoka N., Koeffler H.P. Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505). Leukoc. Res. 23:1999;307-310
28. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:2001;807-869
29. Lavender P., Vandel L., Bannister A.J., Kouzarides T. The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene. 14:1997;2721-2728
30. Lavoie J.N., L'Allemain G., Brunet A., Muller R., Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:1996;20608-20616
31. Lemercier C., Duncliffe K., Boibessot I., Zhang H., Verdel A., Angelov D., Khochbin S. Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression. Mol. Cell Biol. 20:2000;6627-6637
32. + transport-defective yeast and regulation of HBP1, a new putative HMG transcriptional regulator. Nucleic Acids Res. 22:1994;3685-3688
33. Li Y., Hively W.P., Varmus H.E. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene. 19:2000;1002-1009
34. Liang H., Fairman J., Claxton D.F., Nowell P.C., Green E.D., Nagarajan L. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc. Natl. Acad. Sci. U. S. A. 95:1998;3781-3785
35. Liao Y., Hung M.C. Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis. Mol. Cell Biol. 23:2003;6836-6848
36. Lin S.Y., Xia W., Wang J.C., Kwong K.Y., Spohn B., Wen Y., Pestell R.G., Hung M.C. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4262-4266
37. Lin K.M., Zhao W.G., Bhatnagar J., Zhao W.D., Lu J.P., Simko S., Schueneman A., Austin G.E. Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity. Leukemia. 15:2001;601-612
38. Love J.J., Li X., Case D.A., Giese K., Grosschedl R., Wright P.E. Structural basis for DNA bending by the architectural transcription factor Lef-1. Nature (Lond.). 376:1995;791-795
39. Macleod K. pRb and E2f-1 in mouse development and tumorigenesis. Curr. Opin. Genet. Dev. 9:1999;31-39
40. Meng T.C., Fukada T., Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell. 9:2002;387-399
41. Molnar A., Theodoras A.M., Zon L.I., Kyriakis J.M. Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J. Biol. Chem. 272:1997;13229-13235
42. Morris E.J., Dyson N.J. Retinoblastoma protein partners. Adv. Cancer Res. 82:2001;1-54
43. Mu D., Chen L., Zhang X., See L.H., Koch C.M., Yen C., Tong J.J., Spiegel L., Nguyen K.C., Servoss A., Peng Y., Pei L., Marks J.R., Lowe S., Hoey T., Jan L.Y., McCombie W.R., Wigler M.H., Powers S. Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell. 3:2003;297-302
44. Naidu R., Wahab N.A., Yadav M., Kutty M.K. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction. Int. J. Mol. Med. 9:2002;189-196
45. Naidu R., Wahab N.A., Yadav M.M., Kutty M.K. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters. Oncol. Rep. 9:2002;409-416
46. Nimnual A.S., Taylor L.J., Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nat. Cell Biol. 5:2003;236-241
47. Oren M., Damalas A., Gottlieb T., Michael D., Taplick J., Leal J.F., Maya R., Moas M., Seger R., Taya Y., Ben-Ze′Ev A. Regulation of p53: intricate loops and delicate balances. Ann. N. Y. Acad. Sci. 973:2002;374-383
48. Parker S.B., Eichele G., Zhang P., Rawls A., Sands A.T., Bradley A., Olson E.N., Harper J.W., Elledge S.J. p53-independent expression of p21 cip1 in muscle and other terminally differentiated cells. Science. 267:1995;1024-1026
49. Patturajan M., Nomoto S., Sommer M., Fomenkov A., Hibi K., Zangen R., Poliak N., Califano J., Trink B., Ratovitski E., Sidransky D. DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell. 1:2002;369-379
50. Paulson H. Polyglutamine neurodegeneration: minding your Ps and Qs. Nat. Med. 9:2003;825-826
51. Paulson K.E., McDevitt M.A., Christ K.R., Hu M., Sun J., Kim J., Berasi S., Blum J., Band V., Varticowski L., Summerhayes I., Yee A.S. HBP1 Gene Variants in Breast Cancer. 2004;. (manuscript in preparation)
52. Polakis P. Wnt signaling and cancer. Genes Dev. 14:2000;1837-1851
53. Pruitt K., Pruitt W.M., Bilter G.K., Westwick J.K., Der C.J. Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation. J. Biol. Chem. 277:2002;31808-31817
54. Ren B., Cam H., Takahashi Y., Volkert T., Terragni J., Young R.A., Dynlacht B.D. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16:2002;245-256
55. Reya T., Duncan A.W., Ailles L., Domen J., Scherer D.C., Willert K., Hintz L., Nusse R., Weissman I.L. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature (Lond.). 423:2003;409-414
56. Ryo A., Nakamura M., Wulf G., Liou Y.C., Lu K.P. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 3:2001;793-801
57. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14:2000;3037-3050
58. Sampson E.M., Haque Z.K., Ku M.C., Tevosian S.G., Albanese C., Pestell R.G., Paulson K.E., Yee A.S. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J. 20:2001;4500-4511
59. Sauer H., Wartenberg M., Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol. Biochem. 11:2001;173-186
60. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2:2001;731-737
61. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2:2002;103-112
62. Shih H., Tevosian S.G., Yee A.S. Regulation of differentiation by HBP1, a target of the retinoblastoma protein. Mol. Cell. Biol. 18:1998;4732-4743
63. Shih H.H., Xiu M., Berasi S.P., Sampson E.M., Leiter A., Paulson K.E., Yee A.S. HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue. Mol. Cell Biol. 21:2001;5723-5732
64. Sicinski P., Donaher J.L., Parker S.B., Li T., Fazeli A., Gardner H., Haslam S.Z., Bronson R.T., Elledge S.J., Weinberg R.A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 82:1995;621-630
65. Singh B., Lucci A. Role of cyclooxygenase-2 in breast cancer. J. Surg. Res. 108:2002;173-179
66. Spizzo G., Gastl G., Wolf D., Gunsilius E., Steurer M., Fong D., Amberger A., Margreiter R., Obrist P. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. Br. J. Cancer. 88:2003;574-578
67. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 401:1999;79-82
68. Tetsu O., McCormick F. B-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.). 398:1999;422-426
69. Tevosian S.G., Shih H., Mendelson K.G., Sheppard K.A., Paulson K.E., Yee A.S. HBP-1: a new transcriptional repressor that is targeted of the retinoblastoma family. Genes Dev. 11:1997;383-396
70. Trimarchi J.M., Lees J.A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3:2002;11-20
71. Tsukamoto A.S., Grosschedl R., Guzman R.C., Parslow T., Varmus H.E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell. 55:1988;619-625
72. Verdin E., Dequiedt F., Kasler H.G. Class II histone deacetylases: versatile regulators. Trends Genet. 19:2003;286-293
73. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.). 369:1994;669-671
74. Wang S., Nath N., Minden A., Chellappan S. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J. 18:1999;1559-1570
75. Wang X., McGowan C.H., Zhao M., He L., Downey J.S., Fearns C., Wang Y., Huang S., Han J. Involvement of the MKK6-p38 gamma cascade in gamma-radiation-induced cell cycle arrest. Mol. Cell Biol. 20:2000;4543-4552
76. Wang W., Chen J.X., Liao R., Deng Q., Zhou J.J., Huang S., Sun P. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell Biol. 22:2002;3389-3403
77. Weinmann A.S., Yan P.S., Oberley M.J., Huang T.H., Farnham P.J. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev. 16:2002;235-244
78. Weinstat-Saslow D., Merino M.J., Manrow J., Lawrence R.F., Bluth K.D., Wittenbel J.F., Simpson J.F., Page D.L., Steeg P.S. Overexpression of Cyclin d1 mRNA distinguishes invasive and in situ breast carcinoma from non-malignant lesions. Nat. Med. 1:1995;1257-1259
79. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., Yates J.R. III, Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature (Lond.). 423:2003;448-452
80. Wu H., Wade M., Krall L., Grisham J., Xiong Y., Van Dyke T. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell cycle progression, postnatal liver development, and regeneration. Genes Dev. 20:1996;245-260
81. Wu L., Timmers C., Maiti B., Saavedra H.I., Sang L., Chong G.T., Nuckolls F., Giangrande P., Wright F.A., Field S.J., Greenberg M.E., Orkin S., Nevins J.R., Robinson M.L., Leone G. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 414:2001;457-462
82. Wulf G.M., Ryo A., Wulf G.G., Lee S.W., Niu T., Petkova V., Lu K.P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. Embo. J. 20:2001;3459-3472
83. Wulf G., Ryo A., Liou Y.C., Lu K.P. The prolyl isomerase Pin1 in breast development and cancer. Breast Cancer Res. 5:2003;76-82
84. Xiu M., Sampson E., Huang C.Y., Davis R.J., Paulson K.E., Yee A.S. The transcriptional repressor HBP1 is a target of the p38 MAP kinase pathway in cell cycle regulation. Mol. Cell. Biol. 23:2003;8890-8901
85. Xu D., Rovira II, Finkel T. Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev. Cell. 2:2002;251-252
86. Yee A.S., Wang J.Y.-J. The role of RB/E2F in G1 Progression. Boonstra J. G1 Control. 2003;Landes Biosciences, http://www.eurekah.com/chapter.php?chapid= 1053&bookid=74&catid=14
87. Yee A.S., Shih H.S., Tevosian S.G. New perspectives on retinoblastoma family functions in differentiation. Front. Biosci. 3:1998;d532-d547
88. Zenklusen J.C., Thompson J.C., Troncoso P., Kagan J., Conti C.J. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res. 54:1994;6370-6373
89. Zenklusen J.C., Thompson J.C., Klein-Szanto A.J., Conti C.J. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res. 55:1995;1347-1355
90. Zhuma T., Tyrrell R., Sekkali B., Skavdis G., Saveliev A., Tolaini M., Roderick K., Norton T., Smerdon S., Sedgwick S., Festenstein R., Kioussis D. Human HMG box transcription factor HBP1: a role in hCD2 LCR function. EMBO J. 18:1999;6396-6406